EPSRC Core Equipment Award 2022

这项EPSRC核心设备资本奖与我们的机构战略一致，通过促进与其他大学和行业内部和外部资源共享的文化，最大限度地提高研究产出和资本投资的影响，以提高所有学术水平和研究技术专业人员的研究质量、机会和影响，同时确保平等、多样性和包容性。拟议的核心设备将用于促进和加强斯特拉斯克莱德大学广泛的EPS研究和培训活动，这属于EPSRC的战略职权范围，并与我们的能源战略主题保持一致；先进制造与材料；健康和福利；海洋、航空和航天；测量科学与使能技术；创新创业；社会与政策。总的来说，这些核心设备将加强来自理学院和工程学院的许多独立学术小组的研究，分别包括以下部门：生物医学工程系、化学与过程工程系、土木与环境工程系、物理系、纯粹与应用化学系和斯特拉斯克莱德制药与生物医学科学研究所。这将产生重大的学术和商业影响，并为未来的合作和资助应用提供潜力。EPSRC核心设备基本奖包括以下设备：1)分选变形能力细胞仪。这将使我们能够实时分析和分类生物细胞，为基础和应用医学研究调查特性。2)台式x射线衍射仪。这将使我们能够快速检查各种材料的结构，包括材料科学，化学，物理，工程，工业，医疗保健和制造质量控制，从而产生更好的材料设备和更少浪费的制造过程。3)热导率计和气体体积计。这将使我们能够了解各种工程材料的热流特性，从而导致更有效的地源热泵和新的热能储存机会。4)紧凑型便携式光合系统。这将使我们进一步了解植物、土壤和大气之间的相互作用，并创造基础设施，利用这一点来实现环境效益。5) UVC拉曼光谱。它使用紫外线激光来研究原子的振动，从而可以获得材料晶体和化学结构的详细信息。6) iXon Ultra相机。这将使我们能够在非常低的光水平下拍摄照片，以研究少量原子的动力学，并探索该组的行为，这可能会被用于新技术。7)多功能高容量高速台式离心机。这将使研究跨越广泛的研究领域，如光子材料，生物传感器和先进的抗癌疗法。8) Shimadzu 2050液相色谱质谱仪。这将使诊断和治疗方法得到优化。它将使我们了解制造过程对治疗的影响。

This EPSRC Core Equipment capital award aligns with our institutional strategy to maximise research output and impact from capital investment by promoting a culture of resource sharing internally and externally with other universities and industry to enhance research quality, opportunity and impact across all academic levels and Research Technical Professionals whilst ensuring equality, diversity and inclusion. The proposed core equipment will be used to facilitate and strengthen a wide range of EPS research and training activities at the University of Strathclyde, which falls within EPSRC's strategic remit and is aligned to our strategic themes of Energy; Advanced Manufacturing & Materials; Health & Wellbeing; Ocean, Air & Space; Measurement Science & Enabling Technologies; Innovation & Entrepreneurship; and, Society & Policy. Collectively, the core equipment will enhance the research of many independent academic groups from across the Faculties of Science and Engineering respectively including the following departments: Department of Biomedical Engineering, Department of Chemical and Process Engineering, Department of Civil & Environmental Engineering, Department of Physics, Department of Pure and Applied Chemistry and Strathclyde Institute of Pharmacy & Biomedical Sciences. This will as a result deliver significant academic and commercial impact and provide potential for future collaborations and funding applications. The EPSRC Core Equipment Basic award includes the following equipment: 1) Sorting Deformability Cytometer. This will allow us to analyse and sort biological cells in real time, investigating properties for fundamental and applied medical research. 2) Benchtop X-Ray Diffractometer. This will allow us to rapidly examine the structures of various materials across including material science, chemistry, physics, engineering, industry, healthcare, and manufacturing quality control, resulting in better materials devices and manufacturing processes with less waste.3) Thermal conductivity meter and Gas pycnometer. This will allow us to understand the heat flow properties of various engineering materials, leading to more efficient ground-source heat pumps and new thermal energy storage opportunities.4) Compact portable photosynthesis system. This will allow us to further understand the interactions between plants, soil and atmosphere and to create infrastructure to utilise this for environmental benefit. 5) UVC Raman spectroscopy. This uses an Ultra Violet laser to investigate the vibration of atoms, which allows access to detailed information of the crystal and chemical structure of materials.6) iXon Ultra camera. This will allow us to take photographs at very low light levels to study the dynamics of a small number of atoms and to explore the behaviour of the group, which may be harnessed for new technologies.7) Versatile high-capacity high-speed benchtop centrifuge. This will enable research across a wide range research, spanning areas such as a photonic materials, biosensors and advanced anti-cancer therapies. 8) Shimadzu 2050 Liquid chromatography mass spectrometer. This will enable the optimisation of diagnostics and therapeutics. It will allow us to understand the impact of manufacture processes on therapies.